Tech Company Financing Transactions
CrossBridge Bio Funding Round
CrossBridge Bio, based in Houston, scored $10 million from CE Ventures, TMC Venture Fund and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
11/5/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds for the development of its lead program, CBB-120, a potential TROP-2 dual-payload ADC for the treatment of solid tumors, and accelerate the expansion of its pipeline of novel ADC programs.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
2450 Holcombe Blvd. X
Houston, TX 77021
USA
Houston, TX 77021
USA
Phone
Undisclosed
Website
Email Address
Overview
We're insourcing from and bringing world-class scientists, operators, and drug developers to Houston, Texas with seasoned executives and consultants in key functional areas.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Torres
Chief Operating Officer
Abhishake Chhibber
Chief Scientific Officer
Daniel Pereira
Chief Technical Officer
Morris Rosenberg
Browse more venture capital transactions:
Prev: 11/5/2024: Symbiotic Security venture capital transaction
Next: 11/5/2024: Broswarm venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on tech company VC transactions. VC transactions on this site come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs